查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088982

血管閉合器械市場：2026-2032年全球市場預測（依產品類型、手術類型、入路部位、最終用戶及通路分類）

Vascular Closure Device Market by Product Type, Procedure Type, Access Site, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血管閉合裝置市場規模將達到 31.1 億美元，複合年成長率為 7.71%。

主要市場統計數據
基準年 2025 18.5億美元
預計年份：2026年 20億美元
預測年份 2032 31.1億美元
複合年成長率 (%) 7.71%

血管閉合裝置市場簡介

隨著醫院對經導管心血管、周邊血管和結構性心臟治療後更快、更安全地止血的需求日益成長，血管閉塞裝置的市場正在擴大。這些裝置可在股動脈或其他血管穿刺後封閉動脈穿刺部位，與長時間手動壓迫相比，可縮短止血時間，使合適的患者能夠更快地下地行走。

血管閉塞市場的變革性變化

血管閉塞裝置的市場格局正受到入路策略、手術複雜性和醫院效率目標的影響而重塑。臨床證據和專家指南表明，對於合適的患者，橈動脈經皮經皮介入治療（PCI）出血和血管併發症較少，導致股動脈入路的使用減少，許多冠狀動脈介入治療手術轉向橈動脈入路。然而，在橈動脈入路不可行的情況下，對於大直徑和複雜的手術，股動脈閉塞仍然至關重要。

人工智慧對封閉設備的累積影響

人工智慧 (AI) 正開始影響血管閉合器械市場，不僅體現在閉合手術本身，也體現在更廣泛的介入治療過程中。美國食品藥物管理局(FDA) 的人工智慧/機器學習 (AI/ML)醫療設備清單正在迅速擴展，這表明人工智慧在影像、診斷、工作流程最佳化和手術輔助等方面的臨床應用正在加速推進。

關鍵區域洞察：全球對血管閉合裝置的需求

北美地區憑藉經皮的導管室基礎設施、經皮冠狀動脈介入治療（PCI）、經導管主動脈瓣置換術術（TAVR）和周邊血管介入治療的廣泛應用，以及美國食品藥物管理局（FDA）和加拿大衛生署完善的監管流程，仍然是血管閉塞器械的高價值市場。歐洲則擁有成熟的介入性心臟病學網路和歐盟醫療設備法規，這些法規對臨床證據、上市後監測、品管和器械可追溯性提出了更高的要求。

市場優先排序的關鍵群體分析

東協市場受益於心血管基礎設施投資、醫療旅遊以及不斷擴大的私立醫院網路，但採購情況因國家而異，並取決於報銷機制的成熟度。海灣合作理事會（GCC）地區的需求則得益於國家醫療改革計劃、區域公共衛生機構報告的高心血管代謝疾病患病率以及對三級心臟護理的投資，因此，可靠的血管通路閉合對於確保導管室的高效運作至關重要。

血管閉合器械市場主要國家洞察

美國是核心市場，這得益於其高介入手術量、門診治療的普及、先進結構性心臟疾病治療技術的廣泛應用，以及完善的醫療設備核准和監管流程。在加拿大，安全性、價值、省級採購規範和臨床證據備受重視。在墨西哥和巴西，隨著私立醫院、心血管基礎設施的建設以及介入性心臟病學服務可近性的提高，市場機會正在擴大，但報銷機制的差異仍然影響著介入治療的普及。

為行業領導者提供的實用建議

產業領導者應優先考慮以真實世界數據為支撐的臨床差異化，包括止血時間、下床活動時間、穿刺部位併發症併發症率、大口徑血管閉合術中的表現、患者選擇以及總治療成本。具備超音波引導穿刺、支持接受抗凝血治療的患者以及與當日出院流程無縫銜接等功能的器械在醫院推廣應用方面具有顯著優勢。

調查方法和證據

本執行摘要採用二手研究方法，利用公開可用和機構認可的二手信息，包括世界衛生組織 (WHO)、美國食品藥物管理局(FDA) 和經合組織 (OECD) 的健康調查方法、國家心血管組織和監管機構、同行評審的介入性心臟病學文獻、臨床指南和醫療設備法律規範。

結論：血管閉塞裝置的戰略展望

隨著微創心血管和血管內手術在全球的普及，血管閉合器械市場預計將保持其重要性。儘管橈動脈入路已徹底改變了冠狀動脈治療的方式，但對於股動脈和大口徑入路，仍需要可靠的閉合解決方案，以減輕工作流程負擔、支持患者活動，並幫助醫院規範術後恢復流程。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血管閉合裝置市場：依產品類型分類

  • 夾式裝置
  • 膠原蛋白塞裝置
    • 牛膠原蛋白塞
    • 合成膠原膠原蛋白塞
  • 外部壓縮裝置
  • 密封裝置
    • 幾丁聚醣基密封劑
    • 聚乙二醇基密封劑
  • 使用縫線的裝置

第8章 血管閉合器械市場：依手術類型分類

  • 診斷治療
    • 血管造影術
    • 血流動力學監測
  • 介入治療
    • 介入心臟病學
    • 周邊血管介入治療

第9章：血管閉合裝置市場：依入路部位分類

  • 大腿入口
  • 徑向通道

第10章 血管閉合裝置市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第11章 血管閉合裝置市場：依分銷管道分類

  • 直銷
  • 第三方經銷商

第12章 血管閉合器械市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 血管閉合器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 血管閉合器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Acandis GmbH
  • Advanced Vascular Dynamics
  • AngioDynamics Inc
  • Asahi Intecc Co Ltd
  • B Braun Melsungen AG
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Cook Medical LLC
  • Cordis US Corp
  • Forge Medical Inc
  • Haemonetics Corporation
  • Inari Medical Inc
  • iVascular SLU
  • Lepu Medical Technology Beijing Co Ltd
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Morris Innovative Inc
  • Rex Medical LP
  • Teleflex Incorporated
  • Terumo Corporation
  • Transluminal Technologies LLC
  • Tricol Biomedical Inc
  • TZ Medical Inc
  • Vasorum Ltd
  • Vivasure Medical Ltd
  • WL Gore & Associates Inc
Product Code: MRR-ED54C46E8A80

The Vascular Closure Device Market is projected to grow by USD 3.11 billion at a CAGR of 7.71% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.85 billion
Estimated Year [2026] USD 2.00 billion
Forecast Year [2032] USD 3.11 billion
CAGR (%) 7.71%

Vascular Closure Device Market Introduction

The vascular closure device market is expanding as hospitals seek faster, safer hemostasis after catheter-based cardiovascular, peripheral vascular, and structural heart procedures. These devices close arterial access sites after femoral and other vascular punctures, reducing time to hemostasis and ambulation compared with prolonged manual compression in appropriately selected patients.

Demand is supported by the global cardiovascular disease burden: the World Health Organization identifies cardiovascular disease as the leading cause of death worldwide, responsible for an estimated 17.9 million deaths in 2019. Adoption is also tied to minimally invasive interventions, aging populations, day-case catheterization pathways, and continued use of femoral access for large-bore procedures such as transcatheter aortic valve replacement, endovascular aneurysm repair, and mechanical circulatory support.

Transformative Shifts in the Vascular Closure Landscape

The vascular closure device landscape is being reshaped by access-site strategy, procedural complexity, and hospital efficiency goals. Radial access has reduced femoral use in many coronary interventions because clinical evidence and professional guidelines associate radial percutaneous coronary intervention with fewer bleeding and vascular complications in suitable patients. However, femoral artery closure remains essential for large-bore and complex procedures where radial access is not feasible.

Technology development is advancing across suture-mediated, collagen-based, clip-based, plug-based, and resorbable closure systems designed for predictable hemostasis, lower complication risk, and compatibility with larger sheath sizes. Hospitals are also standardizing ultrasound-guided access, anticoagulation protocols, and same-day discharge workflows, making device reliability, clinical evidence, and operator training central purchasing criteria.

Cumulative Impact of Artificial Intelligence on Closure Devices

Artificial intelligence is beginning to influence the vascular closure device market through the broader interventional care pathway rather than through closure alone. The U.S. Food and Drug Administration's public list of AI/ML-enabled medical devices has expanded rapidly, demonstrating accelerating clinical adoption of artificial intelligence in imaging, diagnostics, workflow optimization, and procedural support.

In vascular access management, AI can support pre-procedure risk stratification, vessel assessment from ultrasound or CT imaging, prediction of bleeding and access-site complications, and post-procedure surveillance. For suppliers, AI-enabled analytics can improve inventory planning, complaint trending, training effectiveness, quality systems, and real-world evidence generation. Adoption must remain clinically validated, transparent, and aligned with data privacy and medical device regulatory requirements.

Key Regional Insights Across Global Vascular Closure Demand

North America remains a high-value region for vascular closure devices due to advanced catheterization laboratory infrastructure, strong adoption of percutaneous coronary intervention, transcatheter aortic valve replacement, peripheral interventions, and established regulatory pathways through the U.S. Food and Drug Administration and Health Canada. Europe is shaped by mature interventional cardiology networks and the EU Medical Device Regulation, which raises expectations for clinical evidence, post-market surveillance, quality management, and device traceability.

Asia-Pacific is gaining momentum as China, India, Japan, South Korea, and Australia expand cardiovascular procedure capacity, specialist training, and hospital infrastructure. Latin America, led by Brazil and Mexico, shows steady demand for femoral artery closure and hemostasis management, although reimbursement, procurement, and access remain uneven across public and private systems. The Middle East is investing in specialty cardiac centers, particularly in Gulf economies with national health transformation programs, while Africa remains earlier-stage, with adoption tied to catheterization laboratory availability, clinician training, public-private investment, and broader access to interventional cardiovascular care.

Key Group Insights for Market Prioritization

ASEAN markets are benefiting from cardiovascular infrastructure investment, medical tourism, and growing private hospital networks, although procurement remains fragmented by country and varies with reimbursement maturity. GCC demand is supported by national health transformation programs, high cardiometabolic disease prevalence documented by regional public health authorities, and investment in tertiary cardiac care, making reliable vascular access closure important for efficient cath lab throughput.

The European Union creates a harmonized but more demanding compliance environment under the Medical Device Regulation, favoring suppliers with strong clinical documentation, post-market clinical follow-up, and quality systems. BRICS markets combine large patient populations, expanding cardiovascular care capacity, and cost sensitivity, making local partnerships, education, and tiered access strategies important. G7 countries remain innovation-led and evidence-driven, while NATO member markets often overlap with advanced hospital systems that increasingly emphasize supply-chain resilience, standardized clinical readiness, and compliant medical device procurement.

Key Country Insights in the Vascular Closure Device Market

The United States is a core market due to high interventional procedure volumes, outpatient migration, broad use of advanced structural heart techniques, and established pathways for medical device clearance and surveillance. Canada emphasizes safety, value, provincial procurement discipline, and clinical evidence. Mexico and Brazil present expanding opportunities through private hospitals, cardiovascular infrastructure development, and improving access to interventional cardiology, while reimbursement variability continues to influence adoption.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established catheterization laboratory networks, evidence-based purchasing, and growing demand for efficient post-procedure recovery. Russia places greater emphasis on localization, regulatory continuity, and supply security. In Asia-Pacific, China and India offer scale and rising cardiovascular procedure volumes, Japan prioritizes quality and safety for an aging population, Australia maintains high clinical and regulatory standards, and South Korea combines advanced technology adoption with strong hospital capabilities and specialist interventional expertise.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical differentiation supported by real-world evidence, including time to hemostasis, time to ambulation, access-site complication rates, large-bore closure performance, patient selection, and total cost of care. Devices that integrate smoothly with ultrasound-guided access, anticoagulated patients, and same-day discharge protocols are better positioned for hospital adoption.

Suppliers should strengthen physician training, simulation programs, proctoring, and post-market surveillance while tailoring value propositions by region. In mature markets, health economics, regulatory compliance, and FDA- or MDR-quality evidence are decisive. In emerging markets, affordability, distributor quality, local service, and clinical education drive access. AI-enabled analytics should be used to improve quality systems, demand planning, training impact measurement, and outcomes evidence without overstating unvalidated clinical claims.

Research Methodology and Evidence Base

This executive summary applies a secondary research methodology using publicly available and institutionally recognized sources, including the World Health Organization, U.S. Food and Drug Administration, OECD health indicators, national cardiovascular and regulatory agencies, peer-reviewed interventional cardiology literature, clinical guidelines, and medical device regulatory frameworks.

Insights were triangulated across cardiovascular disease burden, procedure trends, access-site practice patterns, reimbursement environment, regulatory requirements, technology adoption, and hospital workflow priorities. The analysis emphasizes verified directional evidence rather than unsupported market sizing claims, ensuring that conclusions on vascular closure devices, femoral artery closure, large-bore closure, and hemostasis management remain defensible for strategic decision-making.

Conclusion: Strategic Outlook for Vascular Closure Devices

The vascular closure device market is positioned for sustained relevance as minimally invasive cardiovascular and endovascular procedures grow worldwide. While radial access has changed coronary practice, femoral and large-bore access continue to require reliable closure solutions that reduce workflow burden, support patient mobility, and help hospitals standardize post-procedure recovery.

Future competitive advantage will depend on clinical evidence, operator training, regulatory excellence, post-market surveillance, and region-specific market access strategies. Organizations that demonstrate measurable safety, efficiency, and economic value will be best placed to meet demand across mature health systems and emerging healthcare markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vascular Closure Device Market, by Product Type

  • 7.1. Clip Based Devices
  • 7.2. Collagen Plug Devices
    • 7.2.1. Bovine Collagen Plugs
    • 7.2.2. Synthetic Collagen Plugs
  • 7.3. External Compression Devices
  • 7.4. Sealant Based Devices
    • 7.4.1. Chitosan Sealants
    • 7.4.2. Polyethylene Glycol Sealants
  • 7.5. Suture Based Devices

8. Vascular Closure Device Market, by Procedure Type

  • 8.1. Diagnostic Procedures
    • 8.1.1. Angiographic Procedures
    • 8.1.2. Hemodynamic Monitoring
  • 8.2. Interventional Procedures
    • 8.2.1. Cardiovascular Interventions
    • 8.2.2. Peripheral Vascular Interventions

9. Vascular Closure Device Market, by Access Site

  • 9.1. Femoral Access
  • 9.2. Radial Access

10. Vascular Closure Device Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Vascular Closure Device Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Third Party Distributors

12. Vascular Closure Device Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Vascular Closure Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Vascular Closure Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Acandis GmbH
  • 16.3. Advanced Vascular Dynamics
  • 16.4. AngioDynamics Inc
  • 16.5. Asahi Intecc Co Ltd
  • 16.6. B Braun Melsungen AG
  • 16.7. Biotronik SE & Co KG
  • 16.8. Boston Scientific Corporation
  • 16.9. Cardinal Health Inc
  • 16.10. Cook Medical LLC
  • 16.11. Cordis US Corp
  • 16.12. Forge Medical Inc
  • 16.13. Haemonetics Corporation
  • 16.14. Inari Medical Inc
  • 16.15. iVascular SLU
  • 16.16. Lepu Medical Technology Beijing Co Ltd
  • 16.17. Medtronic plc
  • 16.18. Meril Life Sciences Pvt Ltd
  • 16.19. Merit Medical Systems Inc
  • 16.20. Morris Innovative Inc
  • 16.21. Rex Medical LP
  • 16.22. Teleflex Incorporated
  • 16.23. Terumo Corporation
  • 16.24. Transluminal Technologies LLC
  • 16.25. Tricol Biomedical Inc
  • 16.26. TZ Medical Inc
  • 16.27. Vasorum Ltd
  • 16.28. Vivasure Medical Ltd
  • 16.29. W L Gore & Associates Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CLIP BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CLIP BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CLIP BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLLAGEN PLUG DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLLAGEN PLUG DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLLAGEN PLUG DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BOVINE COLLAGEN PLUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BOVINE COLLAGEN PLUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BOVINE COLLAGEN PLUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SYNTHETIC COLLAGEN PLUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SYNTHETIC COLLAGEN PLUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SYNTHETIC COLLAGEN PLUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTERNAL COMPRESSION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTERNAL COMPRESSION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTERNAL COMPRESSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SEALANT BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SEALANT BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SEALANT BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CHITOSAN SEALANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CHITOSAN SEALANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CHITOSAN SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYETHYLENE GLYCOL SEALANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYETHYLENE GLYCOL SEALANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYETHYLENE GLYCOL SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUTURE BASED DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SUTURE BASED DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUTURE BASED DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOGRAPHIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOGRAPHIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOGRAPHIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEMODYNAMIC MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEMODYNAMIC MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEMODYNAMIC MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTERVENTIONAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERVENTIONAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTERVENTIONAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR INTERVENTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR INTERVENTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOVASCULAR INTERVENTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR INTERVENTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR INTERVENTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR INTERVENTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FEMORAL ACCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FEMORAL ACCESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FEMORAL ACCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIAL ACCESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIAL ACCESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIAL ACCESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 151. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 152. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 181. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 182. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 191. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 192. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 193. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 212. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 262. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 269. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 270. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 272. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 274. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 289. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 292. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 294. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 309. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 312. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 313. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 314. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 316. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 319. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 320. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 322. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 323. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 324. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. SOUTH